AQST - Aquestive Therapeutics GAAP EPS of -$0.23 beats by $0.07 revenue of $11.46M beats by $0.42M November, 01 2022 04:42 PM Aquestive Therapeutics Inc. Aquestive Therapeutics press release ( NASDAQ: AQST ): Q3 GAAP EPS of -$0.23 beats by $0.07 . Revenue of $11.46M (-13.7% Y/Y) beats by $0.42M . For further details see: Aquestive Therapeutics GAAP EPS of -$0.23 beats by $0.07, revenue of $11.46M beats by $0.42M